Drawing for GLX

USPTO serial 79381991

GLX

Reviewed by CopyMark Law Group

Reg. 7764290Status 700Registered
Filing date
Status date
Registration date
Apr 22, 2025
Examiner
CREEF, DAVIS W
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GLX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacy J. Grossman

Stacy J. Grossman Law Office of Stacy J. Grossman PLLC500 Mamaroneck Ave, Suite 320Harrison, NY 10528United States

Goods and services

ClassDescriptionStatusFirst use
005Reagents for analytical purposes being reagents for medical purposes; reagents for microbiological analysis being reagents for veterinary purposes; reagents for blood grouping for medical purposes; diagnostic reagents for medical use; biological reagents for medical use; chemical reagents for medical use; diagnostic chemical reagents for medical use; diagnostic biomarker reagents for medical purposesACTIVE—
009Downloadable software for use in data management in the medical field; downloadable computer software relating to the medical field for use in data management; software as a medical device (SaMD), downloadable, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable computer software for use in medical decision support systems, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable health monitoring software; downloadable artificial intelligence software for healthcare, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable machine learning software for healthcare, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable system and system support software, and firmware for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence and machine learning software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence software for analysis of diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable software for making remote medical diagnostics; downloadable machine learning software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable machine learning software for analysis of medical dataACTIVE—
042Computer services, namely, on-site and remote management of information technology (IT) systems of others for the pharmaceutical and healthcare industries; medical and pharmacological research services; software as a service (SaaS) services featuring software platforms using artificial intelligence technology for diagnosing, predicting, prognosticating and monitoring medical conditions; DNA sequencing technology research; blood analysis services for scientific research purposes; software as a service (SaaS) featuring software using machine learning technology for diagnosing, predicting, prognosticating and monitoring medical conditions; software as a service (SaaS) services featuring software using machine learning, deep learning and deep neural network technology for diagnosing, predicting, prognosticating and monitoring medical conditionsACTIVE—
045Health and safety risk management in the nature of security threat analysis for the protection of individuals; health and safety risk assessment services in the nature of security threat analysis for the protection of individuals; licensing of intellectual property; licensing of industrial property rights; legal services; intellectual property licensing services; licensing of intellectual property in the field of copyrights being legal services; licensing of intellectual property in the field of trademarks being legal servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 7, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 7, 2025FIMPFINAL DISPOSITION PROCESSED—
Jul 22, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 22, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 22, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 12, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 25, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 25, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 10, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 10, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Feb 10, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 10, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 10, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 20, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 20, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 20, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 21, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2024RFNTREFUSAL PROCESSED BY IB—
Jun 24, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 24, 2024RFRRREFUSAL PROCESSED BY MPU—
Jun 5, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 5, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2024DOCKASSIGNED TO EXAMINER—
Nov 25, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 31, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 26, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance